Re-engineering CNS drug discovery and development using computer aided modeling Hugo Geerts Editorial 23 November 2020 Article: 7
Molecular docking and pharmacophoric modelling of 1,5-disubstituted tetrazoles as inhibitors of two proteins present in cancer, the ABL and the mutated T315I kinase Erik Díaz-CervantesCarlos J. Cortés-GarcíaAbel Suárez-Castro Original Research 22 November 2020 Article: 6
Hydrochlorothiazide and Indapamide bind the NADPH binding site of bacterial Dihydrofolate Reductase: results of an in-silico study and their implications Sumanpreet KaurRajasri BhattacharyyaDibyajyoti Banerjee Original Research 12 November 2020 Article: 5
In silico predictions on the possible mechanism of action of selected bioactive compounds against breast cancer Aliyu MuhammadBabangida Sanusi KatsayalZak-wan Sidi Umar Original Research 09 November 2020 Article: 4
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 Shravan B. RathodPravin B. PrajapatiMohmedyasin F. Mansuri Original Research 09 November 2020 Article: 3
Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies Opeyemi IwaloyeOlusola Olalekan ElekofehintiToyin Mary Fadipe Original Research 12 September 2020 Article: 2
Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors Monir UzzamanTareq Mahmud Original Research 04 March 2020 Article: 1